Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medical Device Innovation Consortium Advances Regulatory Science Projects

This article was originally published in The Gray Sheet

Executive Summary

At the Regulatory Affairs Professionals Society annual meeting last week, William Hawkins, chairman of the Medical Device Innovation Consortium, said the group is making progress in its first project on computer modeling and simulation, as well as future projects on clinical trial reform, and benefit-risk guidance and patient-centeredness.


Related Content

Replacing Test Subjects With Computer Models Will Take Cooperation
Device Innovation Consortium Plans To Finish Patient-Centered Project This Year
FDA Expects Guidance On Validating Device Development Tools To Speed Approvals
Shutdown Realities At FDA: No New Submission Reviews, And More
FDA Validates Tool For Incorporating Patient Preferences In Regulatory Decisions
People Briefs: Device Consortium Appoints CEO
Medical Device Innovation Consortium Sets Priorities To Advance Reg Science
Medical Device Innovation Consortium Launches, Aims To Start Projects In 2013


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts